Inovalon Holdings, Inc. - (INOV): Price and Financial Metrics

Inovalon Holdings, Inc. - (INOV): $37.39

-0.49 (-1.29%)

POWR Rating

Component Grades














  • Growth is the dimension where INOV ranks best; there it ranks ahead of 99.96% of US stocks.
  • INOV's strongest trending metric is Growth; it's been moving up over the last 31 weeks.
  • INOV's current lowest rank is in the Value metric (where it is better than 26.52% of US stocks).

INOV Stock Summary

  • With a one year PEG ratio of 1,227.85, Inovalon Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.24% of US stocks.
  • With a price/earnings ratio of 176.79, Inovalon Holdings Inc P/E ratio is greater than that of about 95.65% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for Inovalon Holdings Inc is higher than 86.02% of stocks in our set with a positive cash flow.
  • Stocks that are quantitatively similar to INOV, based on their financial statements, market capitalization, and price volatility, are WING, NEOG, SYNH, MRCY, and KAI.
  • INOV's SEC filings can be seen here. And to visit Inovalon Holdings Inc's official web site, go to

INOV Valuation Summary

  • INOV's EV/EBIT ratio is 68.6; this is 106.32% higher than that of the median Technology stock.
  • INOV's EV/EBIT ratio has moved up 31.9 over the prior 78 months.
  • Over the past 78 months, INOV's EV/EBIT ratio has gone up 31.9.

Below are key valuation metrics over time for INOV.

Stock Date P/S P/B P/E EV/EBIT
INOV 2020-12-15 4.7 4.5 544.2 63.6
INOV 2019-05-10 3.6 3.1 -68.0 121.6
INOV 2018-08-29 3.8 2.6 -991.9 -1115.9
INOV 2017-07-13 4.2 2.7 64.0 41.5
INOV 2016-12-30 3.4 2.1 35.8 22.0
INOV 2015-12-03 7.0 3.9 44.6 25.5

INOV Growth Metrics

  • Its 3 year revenue growth rate is now at 30.05%.
  • Its 4 year net cashflow from operations growth rate is now at 30.59%.
  • The 4 year net income to common stockholders growth rate now stands at -74.52%.
Over the past 30 months, INOV's revenue has gone up $184,532,000.

The table below shows INOV's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 690.513 164.696 32.45
2020-12-31 667.524 146.359 21.906
2020-09-30 651.268 143.335 5.654
2020-06-30 656.344 129.699 11.475
2020-03-31 651.106 105.824 13.914
2019-12-31 642.41 106.48 7.538

INOV Price Target

For more insight on analysts targets of INOV, see our INOV price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $29.38 Average Broker Recommendation 1.61 (Moderate Buy)

INOV Stock Price Chart Interactive Chart >

Price chart for INOV

INOV Price/Volume Stats

Current price $37.39 52-week high $38.60
Prev. close $37.88 52-week low $17.56
Day low $37.31 Volume 113,615
Day high $37.85 Avg. volume 521,615
50-day MA $32.99 Dividend yield N/A
200-day MA $26.82 Market Cap 5.83B

Inovalon Holdings, Inc. - (INOV) Company Bio

Inovalon Holdings provides advanced cloud-based data analytics and data-driven intervention platforms to the healthcare industry in the United States. The company was founded in 1998 and is based in Bowie, Maryland.

INOV Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$37.39$6.55 -79%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Inovalon Holdings Inc. To summarize, we found that Inovalon Holdings Inc ranked in the 20th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for INOV, they are:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 83. Notably, its equity weight is greater than only 24.29% of US equities in the Technology sector yielding a positive free cash flow.
  • Inovalon Holdings Inc's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 62.22% of tickers in our DCF set.
  • Inovalon Holdings Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as INOV, try ASML, CYBR, HLIT, TRT, and VRSN.

INOV Latest News Stream

Event/Time News Detail
Loading, please wait...

INOV Latest Social Stream

Loading social stream, please wait...

View Full INOV Social Stream

Latest INOV News From Around the Web

Below are the latest news stories about Inovalon Holdings Inc that investors may wish to consider to help them evaluate INOV as an investment opportunity.

Were Hedge Funds Right About Inovalon Holdings Inc (INOV)?

In this article we will check out the progression of hedge fund sentiment towards Inovalon Holdings Inc (NASDAQ:INOV) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]

Yahoo | July 30, 2021

Inovalon Holdings, Inc. (INOV) CEO Dr. Keith Dunleavy on Q2 2021 Results - Earnings Call Transcript

Inovalon Holdings, Inc. (INOV) Q2 2021 Results Conference Call July 28, 2021 05:00 PM ET Company Participants Kim Collins - Senior Vice President-Communications Dr. Keith Dunleavy - Chief Executive Officer Jonathan Boldt - Chief Financial Officer Conference Call Participants Daniel Grosslight - Citi Stephanie Davis - SVB Leerink Jessica Tassan...

SA Transcripts on Seeking Alpha | July 29, 2021

Inovalon Holdings (INOV) Q2 Earnings and Revenues Surpass Estimates

Inovalon Holdings (INOV) delivered earnings and revenue surprises of 18.75% and 3.56%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | July 28, 2021

Inovalon Reports Second Quarter 2021 Results

Second Quarter 2021 Highlights Q2 revenue of $190.4 million, up 17% YoY and 8% sequentiallyQ2 subscription-based platform revenue of $168.7 million, up 19% YoY and 7% sequentially, equating to 89% of Q2 total revenueQ2 net income of $9.6 million, resulting in diluted net income of $0.06 per shareQ2 Non-GAAP net income of $27.9 million, resulting in Non-GAAP net income of $0.19 per share, up 27% YoYQ2 Adjusted EBITDA of $64.1 million, up 13% YoY and 9% sequentially, resulting in adjusted EBITDA m

Yahoo | July 28, 2021

Healthcare Analytics Market SWOT Analysis to 2026 Players are Cerner Corporation, Health Catalyst, Inovalon, McKesson Corporation, MEDEANALYTICS, Optum, Inc

A new market study is released on Global "Healthcare Analytics Market 2021" with data Tables for historical and forecast years represented with Chats & Graphs with easy to understand detailed analysis. The report also sheds light on present scenario and

OpenPR | July 27, 2021

Read More 'INOV' Stories Here

INOV Price Returns

1-mo 10.82%
3-mo 22.63%
6-mo 45.15%
1-year 58.90%
3-year 206.48%
5-year 94.03%
YTD 105.78%
2020 -3.45%
2019 32.72%
2018 -5.47%
2017 45.63%
2016 -39.41%

Continue Researching INOV

Want to see what other sources are saying about Inovalon Holdings Inc's financials and stock price? Try the links below:

Inovalon Holdings Inc (INOV) Stock Price | Nasdaq
Inovalon Holdings Inc (INOV) Stock Quote, History and News - Yahoo Finance
Inovalon Holdings Inc (INOV) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0389 seconds.